These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1400978)

  • 41. Microbiology of airway disease in patients with cystic fibrosis.
    Gilligan PH
    Clin Microbiol Rev; 1991 Jan; 4(1):35-51. PubMed ID: 1900735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil.
    Santana MA; Matos E; do Socorro Fontoura M; Franco R; Barreto D; Lemos AC
    Braz J Infect Dis; 2003 Feb; 7(1):69-72. PubMed ID: 12807693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum.
    Conrad DA; Scribner RK; Weber AH; Marks MI
    Antimicrob Agents Chemother; 1985 Jul; 28(1):58-63. PubMed ID: 3929681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacitracin agar vs. oleandomycin disk supplemented chocolate agar for the recovery of Haemophilus influenzae in diagnostic samples: A prospective comparison.
    Forstner P; Laireiter CM; Friedl S; Steinmetz I; Dichtl K
    Diagn Microbiol Infect Dis; 2024 May; 109(1):116203. PubMed ID: 38422664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexistence of Candida species and bacteria in patients with cystic fibrosis.
    Haiko J; Saeedi B; Bagger G; Karpati F; Özenci V
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1071-1077. PubMed ID: 30739228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].
    Busquets NP; Baroni MR; Ochoteco MC; Zurbriggen ML; Virgolini S; Meneghetti FG
    Rev Argent Microbiol; 2013; 45(1):44-9. PubMed ID: 23560788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystic fibrosis: infection.
    Høiby N
    Schweiz Med Wochenschr; 1991 Jan; 121(4):105-9. PubMed ID: 1900640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-count organisms concealed by dominant uropathogenic organisms in urine of patients with asymptomatic bacteriuria.
    Sakai Y
    Int J Urol; 1995 May; 2(2):96-9. PubMed ID: 7553296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients.
    Velikova N; Wells JM
    Curr Drug Targets; 2017; 18(6):687-695. PubMed ID: 26853320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Bacti-Lab streptococci culture systems for selective recovery and identification of group A streptococci.
    Freeburg PW; Buckingham JM
    J Clin Microbiol; 1976 Apr; 3(4):443-8. PubMed ID: 816808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
    Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD
    Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemophilus influenzae in genitourinary tract infections.
    Hall GD; Washington JA
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):65-70. PubMed ID: 6608436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bacteriological and mycological analysis of material taken from lower respiratory tract in patients with malignancy].
    Szymankiewicz M; Kowalewski J; Dancewicz M
    Pol Merkur Lekarski; 2006 Sep; 21(123):218-22. PubMed ID: 17163180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade.
    Raidt L; Idelevich EA; Dübbers A; Küster P; Drevinek P; Peters G; Kahl BC
    Pediatr Infect Dis J; 2015 Jul; 34(7):700-5. PubMed ID: 25851069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.
    Müller FM; Seidler M
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):957-64. PubMed ID: 20695750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis.
    Renders N; Verbrugh H; Van Belkum A
    Infect Genet Evol; 2001 Jul; 1(1):29-39. PubMed ID: 12798048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of novel vancomycin-containing medium for primary isolation of Kingella kingae from upper respiratory tract specimens.
    Yagupsky P; Merires M; Bahar J; Dagan R
    J Clin Microbiol; 1995 May; 33(5):1426-7. PubMed ID: 7615773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.